|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities, net of effects of acquisitions: | |||||
| Net Income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Provision for loan losses | |||||
| (Reversal) provision for unfunded commitments | |||||
| Depreciation | |||||
| Amortization and accretion of purchase accounting valuations and intangibles | |||||
| Losses on equity investments | |||||
| Federal Home Loan Bank stock dividends | |||||
| Net amortization of premium on investments | |||||
| Amortization of subordinated debt issuance cost | |||||
| Loss on sale of securities, net | |||||
| Gain on sale of loans, net | |||||
| (Gain) loss on sale of assets, net | |||||
| Proceeds, including principal payments, from loans held for sale | |||||
| Originations of loans held for sale | |||||
| Non-cash compensation | |||||
| Deferred income tax benefit | |||||
| Decrease (increase) in accrued interest receivable and other assets | |||||
| Increase in cash surrender value of bank-owned life insurance | |||||
| (Decrease) increase in accrued interest payable and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities, net of effects of acquisitions: | |||||
| Purchases of securities available for sale | |||||
| Proceeds from maturities, prepayments and calls on securities available for sale | |||||
| Proceeds from maturities, prepayments and calls on securities held to maturity | |||||
| Proceeds from sales on securities available for sale | |||||
| Increase in loans, net | |||||
| Decrease in interest-bearing deposits in banks | |||||
| Proceeds from sale of foreclosed assets | |||||
| Purchases of office properties and equipment | |||||
| Net cash disbursed in sale of banking center | |||||
| Net cash disbursed in business combination | |||||
| Proceeds from sale of office properties and equipment | |||||
| Purchase of bank-owned life insurance | |||||
| Proceeds from bank-owned life insurance | |||||
| Purchase of Federal Home Loan Bank stock | |||||
| Proceeds from redemption of Federal Home Loan Bank stock | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities, net of effects of acquisitions: | |||||
| Increase in deposits, net | |||||
| Borrowings on Federal Home Loan Bank advances | |||||
| Repayments of Federal Home Loan Bank advances | |||||
| Proceeds from issuance of subordinated debt, net of issuance cost | |||||
| Repayments of other borrowings | |||||
| Proceeds from exercise of stock options | |||||
| Issuance of stock under incentive plans | |||||
| Dividends paid to shareholders | |||||
| Purchase of Company’s common stock | |||||
| Net cash (used in) provided by financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplementary cash flow information: | |||||
| Interest paid on deposits and borrowed funds | |||||
| Income taxes paid | |||||
| Noncash investing and financing activities: | |||||
| Loans transferred to ORE, net of charge offs | |||||
| Recognition of new operating leases | |||||
Loading...
